19
1
49
2
2
18
1b
1d
18
32
59
1d
2 29
1d
25
David M. Mintzer, MD
88
59
Clinical Professor of Medicine (Hematology-Oncology)
28
8e
3
5f
Attending Physician, Pennsylvania Oncology Hematology Associates, Pennsylvania Hospital
7b
Chief, Section of Hematology/Medical Oncology, Pennsylvania Hospital
67
Member, University of Pennsylvania Cancer Center
65
Penn Medicine Clinician, Pennsylvania Hospital
11
Department: Medicine
4
1
b
1d
46
Contact information
43
4
3
3
3
2
4
b
1f
43
Pennsylvania Hospital
37 Abramson Cancer Center at Pennsylvania Hospital
1d Farm Journal Building
48 230 West Washington Square, 2nd Floor
Philadelphia, PA 19106
26
37 Abramson Cancer Center at Pennsylvania Hospital
1d Farm Journal Building
48 230 West Washington Square, 2nd Floor
Philadelphia, PA 19106
2e
Office: 215-829-7704
32 Fax: 215-829-6104
24
a9
12
32 Fax: 215-829-6104
24
13
Education:
21 7 BS 1d (General Sciences) c
61 Pennsylvania State University , Combined Accelerated Program in Medicine, 1975.
21 7 MD c
32 Jefferson Medical College, 1977.
c
3
3
3
3
8a
Permanent link21 7 BS 1d (General Sciences) c
61 Pennsylvania State University , Combined Accelerated Program in Medicine, 1975.
21 7 MD c
32 Jefferson Medical College, 1977.
c
2 29
21
1e
1d
24
2b
29
27
23
fb Mintzer D, Henry D: FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies. MDEdge March 2021 Notes: podcast.
d6 Mintzer D, Henry D: FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs. MDEdge February 2021 Notes: podcast.
dc David Mintzer: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship. American College of Physicians 2021.
9c Deye, DL; Mintzer D: MKSAP 19 Audio companion. Oakstone. Oakstone Publishing, 2021.
de Mintzer D: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship. American College of Physicians. ACP, 2021.
cb Bryer E, Mintzer D, Henry DH: 2019 At a Glance: Hem-Onc U.S. Drug Approvals. MDedge/Hematology and Oncology October 31, 2019 2019.
156 Emily Bryer, Monique Neault, David Mintzer: Managing Dying: Medical Care and Decision Making at the Very End-of-Life. Palliative Medicine & Care: Open Access. https://symbiosisonlinepublishing.com/ Page: DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180, August 2019.
104 Bryer E, Mintzer D, Henry D: 2018 At A Glance: Recently Approved Therapies in Oncology. MD Edge/Hematology and Oncology Page: ://mdedge-files-live.s3.us-east-2.amazonaws.com, April 2019.
143 Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC: Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). Leukemia and Lymphoma Page: 1-4, Mar 2019.
2c
7
1d
1f
Selected Publications
99 David M. Mintzer: But Where is My Doctor? The Increasing and Relentless Fragmentation of Oncology Care 2 6b Journal of Clinical Oncology 41(26): 4313, 2023 Notes: DOI: 10.1200/JCO.23.00805.fb Mintzer D, Henry D: FDA approvals in hematology and oncology, Part II: New oral formulations, RET and MET inhibitors, and CAR T-cell therapies. MDEdge March 2021 Notes: podcast.
d6 Mintzer D, Henry D: FDA approvals in hematology and oncology: Novel agents and new tricks for old drugs. MDEdge February 2021 Notes: podcast.
dc David Mintzer: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship. American College of Physicians 2021.
9c Deye, DL; Mintzer D: MKSAP 19 Audio companion. Oakstone. Oakstone Publishing, 2021.
de Mintzer D: MKSAP 19, Oncology, Sections on lymphoma, melanoma, effects of cancer therapy and survivorship. American College of Physicians. ACP, 2021.
cb Bryer E, Mintzer D, Henry DH: 2019 At a Glance: Hem-Onc U.S. Drug Approvals. MDedge/Hematology and Oncology October 31, 2019 2019.
156 Emily Bryer, Monique Neault, David Mintzer: Managing Dying: Medical Care and Decision Making at the Very End-of-Life. Palliative Medicine & Care: Open Access. https://symbiosisonlinepublishing.com/ Page: DOI: http://dx.doi.org/10.15226/2374-8362/6/1/00180, August 2019.
104 Bryer E, Mintzer D, Henry D: 2018 At A Glance: Recently Approved Therapies in Oncology. MD Edge/Hematology and Oncology Page: ://mdedge-files-live.s3.us-east-2.amazonaws.com, April 2019.
143 Deshields TL, Dueck AC, Rogers K, Brown JR, Shanafelt T, Mintzer D, Byrd JC: Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance). Leukemia and Lymphoma Page: 1-4, Mar 2019.
2c